Scientific Community Responds to AI-Designed Protocol
Australia’s AI Vaccine: ChatGPT Aids Dog’s Cancer Care
Consultant Paul Conyngham used AI to design an experimental treatment for his dog, Rosie, achieving partial remission.

An Australian man sits with his rescue dog, Rosie, who received an experimental AI-designed cancer treatment.
Photo: Avantgarde News
Australian consultant Paul Conyngham used ChatGPT to research and design an experimental cancer vaccine for his rescue dog, Rosie [1]. The project focused on treating the dog's mast cell cancer through a personalized protocol [1]. On March 30, 2026, reports confirmed the treatment led to partial remission for the animal [1][2]. The innovative use of generative AI has caught the attention of OpenAI CEO Sam Altman and the broader scientific community [1]. While the case demonstrates potential for personalized veterinary medicine, it also highlights new frontiers in AI-assisted biological research [1]. The story has since gone viral globally as experts weigh the implications of AI-designed medical treatments [1][2].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
The risk level is high because the story involves non-professional medical treatment designed by AI, which carries significant safety and liability concerns.
Sources
Related stories
View allTopics
About the author
Avantgarde News Desk covers scientific community responds to ai-designed protocol and editorial analysis for Avantgarde News.


